[1] |
YAMANOUCHI T,AKANUMA Y.Serum 1,5-anhydroglucitol(1,5 AG):new clinical marker for glycemic control[J]. Diabetes Res Clin Pract,1994,24(Suppl):S261-S268.
|
[2] |
KOGA M,KASAYAMA S.Clinical impact of glycated albumin as another glycemic control marker[J]. Endocr J,2010,57(9):751-762.
|
[3] |
American Diabetes Association.Standards of medical care in diabetes-2012[J]. Diabetes Care,2012,35(Suppl 1):S11-S63.
|
[4] |
SELVIN E,CRAINICEANU C M,BRANCATI F L,et al.Short-term variability in measures of glycemia and implications for the classification of diabetes[J]. Arch Intern Med,2007,167(14):1545-1551.
|
[5] |
PITKÄNEN E. 1,5-anhydro-D-glucitol-a novel type of sugar in the human organism[J]. Scand J Clin Lab Invest Suppl,1990,201:55-62.
|
[6] |
YAMANOUCHI T,TACHIBANA Y,AKANUMA H,et al.Origin and disposal of 1,5-anhydroglucitol,a major polyol in the human body[J]. Am J Physiol,1992,263(2 Pt 1):E268-E273.
|
[7] |
YAMANOUCHI T,AKANUMA H,NAKAMURA T,et al.Reduction of plasma 1,5-anhydroglucitol(1-deoxyglucose) concentration in diabetic patients[J]. Diabetologia,1988,3(1):41-45.
|
[8] |
KAMETANI S,HASHIMOTO Y,YAMANOUCHI T,et al.Reduced renal reabsorption of 1,5-anhydro-D -glucitol in diabetic rats and mice[J]. J Biochem,1987,102(6):1599-1607.
|
[9] |
BUSE J B,FREEMAN J L,EDELMAN S V,et al. Serum 1,5-anhydroslucitol(GlycoMark):a short-term glycemic marker[J]. Diabetes Technol Ther,2003,5(3):355-363.
|
[10] |
张颖,于永光,刘倩. 酶偶联法测定1,5-脱水葡糖苷方法学建立[J]. 中华临床医师杂志(电子版),2012,6(4):1031-1032.
|
[11] |
FUKUMURA Y,TAJIMA S,OSHITANI S,et al.Fully enzymatic method for determining 1,5-anhydro-D-glucitol in serum[J]. Clin Chem,1994,40(11 Pt 1):2013-2016.
|
[12] |
郭建华,李莉,李晓强,等. 两种全酶法测定1,5-脱水葡萄糖醇方法比较[J]. 郧阳医学院学报,2005,24(4):238-239.
|
[13] |
SAGLAM B,UYSAL S,SOZDINLER S,et al.Diagnostic value of glycemic markers HbA1c,1,5-anhydroglucitol and glycated albumin in evaluating gestational diabetes mellitus[J]. Ther Adv Endocrinol Metab,2017,8(12):161-167.
|
[14] |
WANG Y,YUAN Y,ZHANG Y,et al.Serum 1,5-anhydroglucitol level as a screening tool for diabetes mellitus in a community-based population at high risk of diabetes[J]. Acta Diabetol,2017,54(5):425-431.
|
[15] |
JAGANNATHAN R,SEVICK M A,FINK D,et al.The 1-hour post-load glucose level is more effective than HbA1c for screening dysglycemia[J]. Acta Diabetol,2016,53(4):543-550.
|
[16] |
KO G T,CHAN J C,YEUNG V T,et al.Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects[J]. Diabetes Care,1998,21(8):1221-1225.
|
[17] |
张抗,万雄萍. 血浆1,5脱水葡糖醇在糖尿病监测中的应用和测定方法的进展[J]. 临床检验杂志,2000,18(6):378-380.
|
[18] |
张颖,朱铁虹. 1,5-脱水山梨醇对糖尿病早期诊断的意义[J]. 医学综述,2008,14(7):1077-1079.
|
[19] |
KIM K K,JUNG H S,KWAK S H,et al.1,5-Anhydro-D-glucitol could reflect hypoglycemia risk in patients with type 2 diabetes receiving insulin therapy[J]. Endocrinol Metab(Seoul),2016,31(2):284-291.
|
[20] |
SELVIN E,RAWLINGS A,LUTSEY P,et al.Association of 1,5-anhydroglucitol with cardiovascular disease and mortality[J]. Diabetes,2016,65(1):201-208.
|